Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial

Authors: Man‐Fung Yuen, Kosh Agarwal, Edward Gane, Christian Schwabe, Sang Hoon Ahn, Dong Joon Kim, Young‐Suk Lim, Wendy Cheng, William Sievert, Kumar Visvanathan, Eric Ruby, Sandy Liaw, Ran Yan, Qi Huang, Richard J. Colonno, Uri Lopatin - The Lancet 2019 cited by 107